29.06.2013 Views

SEC Form 20-F - Deutsche Bank Annual Report 2012

SEC Form 20-F - Deutsche Bank Annual Report 2012

SEC Form 20-F - Deutsche Bank Annual Report 2012

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Deutsche</strong> <strong>Bank</strong> Consolidated Financial Statements F-10<br />

<strong>Annual</strong> <strong>Report</strong> <strong>20</strong>10 on <strong>Form</strong> <strong>20</strong>-F Consolidated Statement of Cash Flows<br />

Consolidated Statement of Cash Flows<br />

in € m. <strong>20</strong>10 <strong>20</strong>09 <strong>20</strong>08<br />

Net income (loss) 2,330 4,958 (3,896)<br />

Cash flows from operating activities:<br />

Adjustments to reconcile net income to net cash provided by (used in) operating activities:<br />

Provision for credit losses 1,274 2,630 1,076<br />

Restructuring activities – – –<br />

Gain on sale of financial assets available for sale, equity method investments, and other (363) (656) (1,732)<br />

Deferred income taxes, net 315 (296) (1,525)<br />

Impairment, depreciation and other amortization, and accretion 4,255 1,782 3,047<br />

Share of net income from equity method investments (457) (189) (53)<br />

Income (loss) adjusted for noncash charges, credits and other items 7,354 8,229 (3,083)<br />

Adjustments for net change in operating assets and liabilities:<br />

Interest-earning time deposits with banks (34,806) 4,583 (3,964)<br />

Central bank funds sold, securities purchased under resale agreements, securities borrowed 26,368 (4,<strong>20</strong>3) 24,363<br />

Trading assets and positive market values from derivative financial instruments (27,237) 726,237 (472,<strong>20</strong>3)<br />

Financial assets designated at fair value through profit or loss (24,502) 24,890 169,423<br />

Loans (2,823) 17,213 (37,981)<br />

Other assets (5,894) 21,960 38,573<br />

Deposits 22,656 (57,330) (56,918)<br />

Trading liabilities and negative market values from derivative financial instruments 9,549 (686,214) 655,218<br />

Financial liabilities designated at fair value through profit or loss and investment contract liabilities 53,450 (7,061) (159,613)<br />

Central bank funds purchased, securities sold under repurchase agreements, securities loaned (40,709) (40,644) (97,009)<br />

Other short-term borrowings 18,509 2,592 (14,216)<br />

Other liabilities 2,851 (15,645) (15,482)<br />

Senior long-term debt (3,457) (7,150) 12,769<br />

Other, net (4,985) (1,243) (2,760)<br />

Net cash provided by (used in) operating activities (3,676) (13,786) 37,117<br />

Cash flows from investing activities:<br />

Proceeds from:<br />

Sale of financial assets available for sale 10,652 9,023 19,433<br />

Maturities of financial assets available for sale 4,181 8,938 18,713<br />

Sale of equity method investments 250 574 680<br />

Sale of property and equipment 108 39 107<br />

Purchase of:<br />

Financial assets available for sale (14,087) (12,082) (37,819)<br />

Equity method investments (145) (3,730) (881)<br />

Property and equipment (873) (592) (939)<br />

Net cash received in (paid for) business combinations/divestitures 8,580 (<strong>20</strong>) (24)<br />

Other, net (1,189) (1,749) (39)<br />

Net cash provided by (used in) investing activities 7,477 401 (769)<br />

Cash flows from financing activities:<br />

Issuances of subordinated long-term debt 1,341 457 523<br />

Repayments and extinguishments of subordinated long-term debt (229) (1,448) (659)<br />

Issuances of trust preferred securities 90 1,303 3,404<br />

Repayments and extinguishments of trust preferred securities (51) – –<br />

Common shares issued under share-based compensation plans – – 19<br />

Capital increase 10,060 – 2,<strong>20</strong>0<br />

Purchases of treasury shares (15,366) (19,238) (21,736)<br />

Sale of treasury shares 13,519 18,111 21,426<br />

Dividends paid to noncontrolling interests (7) (5) (14)<br />

Net change in noncontrolling interests <strong>20</strong>0 109 331<br />

Cash dividends paid (465) (309) (2,274)<br />

Net cash provided by (used in) financing activities 9,092 (1,0<strong>20</strong>) 3,2<strong>20</strong><br />

Net effect of exchange rate changes on cash and cash equivalents 1,911 690 (402)<br />

Net increase (decrease) in cash and cash equivalents 14,804 (13,715) 39,166<br />

Cash and cash equivalents at beginning of period 51,549 65,264 26,098<br />

Cash and cash equivalents at end of period 66,353 51,549 65,264<br />

Net cash provided by (used in) operating activities include<br />

Income taxes paid (received), net 784 (5<strong>20</strong>) (2,495)<br />

Interest paid 13,740 15,878 43,724<br />

Interest and dividends received 29,456 28,211 54,549<br />

Cash and cash equivalents comprise<br />

Cash and due from banks 17,157 9,346 9,826<br />

Interest-earning demand deposits with banks (not included: time deposits of € 43,181 m. as of December<br />

31, <strong>20</strong>10, and € 5,030 m. and € 9,301 m. as of December 31, <strong>20</strong>09 and <strong>20</strong>08) 49,196 42,<strong>20</strong>3 55,438<br />

Total 66,353 51,549 65,264<br />

The accompanying notes are an integral part of the Consolidated Financial Statements.<br />

The acquisition of <strong>Deutsche</strong> Postbank AG shares, including the non-cash portion, is described in detail in Note 04 “Acquisitions and Dispositions”. The restructuring of<br />

loans the Group held with the Icelandic generic pharmaceutical group Actavis Group hF resulted in a non-cash reclassification of the subordinated financing arrange-<br />

ment from operating to investing activities for the purposes of the Consolidated Statement of Cash Flows. The transaction is described in detail in Note 17 “Equity<br />

Method Investments”.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!